Securities code: Guanhao Biotech Co.Ltd(300238) securities abbreviation: Guanhao Biotech Co.Ltd(300238) Announcement No.: 2022023 Guanhao Biotech Co.Ltd(300238)
Announcement of resolutions of the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guanhao Biotech Co.Ltd(300238) (hereinafter referred to as “the company”) the 2021 annual general meeting of shareholders was held at 14:30 p.m. on May 18, 2022 in the conference room of the company, No. 12, Yuyan Road, Huangpu District, Guangzhou. A total of 18 shareholders and authorized representatives of shareholders attended the meeting, representing 78212732 shares, accounting for 294969% of the total share capital of the company. 5 shareholders and shareholder representatives attended the on-site meeting, holding 55128322 shares, accounting for 207909% of the total share capital of the company; 13 shareholders participated in online voting, holding 23084410 shares, accounting for 8.7060% of the total share capital of the company. This meeting complies with the relevant provisions of laws, regulations and the articles of association. The meeting was presided over by Mr. Wang Xinzhi, vice chairman. Some directors, supervisors, senior executives and witness lawyers of the company attended the meeting. 1、 Convening and attendance of the meeting
The company issued the notice on convening the 2021 annual general meeting of shareholders on April 15, 2022, the announcement on adding interim proposals and supplementary notice of the 2021 annual general meeting of shareholders on May 6, 2022, and the suggestive announcement on convening the 2021 annual general meeting of shareholders on May 14, 2022 (see the gem information disclosure website designated by the CSRC for details)（ http://www.cn.info.com.cn. ）。
（1） Meeting time: 14:30 PM, May 18, 2022
（2） Meeting place: conference room of the company, No. 12, Yuyan Road, Huangpu District, Guangzhou
（3） Meeting mode: the combination of on-site voting and online voting is adopted. On site meeting time: 14:30 PM, May 18, 2022. The voting time of Shenzhen stock exchange is from 13:00 a.m. to 15:30 p.m. on the Internet, and the voting time is from 13:00 a.m. to 15:30 p.m. on May 9, 2029; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 a.m. on May 18, 2022 to 15:00 p.m. on May 18, 2022.
（4） Convener: Board of directors
（5） Moderator: Mr. Wang Xinzhi, vice chairman and general manager of the company
The convening and convening of this meeting comply with the company law, the rules for the general meeting of shareholders of listed companies and other laws, regulations and normative documents, as well as the relevant provisions of the articles of association.
The annual general meeting of shareholders was convened by the board of directors of the company and presided over by Mr. Wang Xinzhi, vice chairman and general manager. Some directors, supervisors, senior executives and witness lawyers of the company attended the meeting. General attendance of shareholders: 18 shareholders and their authorized representatives attended the meeting, representing 78212732 shares, accounting for 294969% of the total share capital of the company. 5 shareholders and their representatives attended the on-site meeting, holding 55128322 shares, accounting for 207909% of the total share capital of the company; 13 shareholders participated in online voting, holding 23084410 shares, accounting for 8.7060% of the total share capital of the company. Overall attendance of minority shareholders: 15 minority shareholders voted on the spot and online, representing 7786644 shares, accounting for 2.9366% of the total shares of the listed company. Among them, there are 3 minority shareholders voting on site, representing 68500 shares, accounting for 0.0258% of the total shares of the listed company. 12 minority shareholders voted online, representing 7718144 shares, accounting for 2.9108% of the total shares of the listed company.
2、 Deliberation and voting of proposals
The meeting adopts the combination of on-site voting and online voting. The voting situation is as follows:
(I) deliberating and adopting the work report of the board of directors in 2021
Voting results: 78147328 shares were approved, accounting for 999164% of the shares held by all shareholders attending the meeting; Oppose 400 shares, accounting for 0.0005% of the shares held by all shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.0831% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the company’s shares: 7721240 shares, accounting for 991600% of the shares held by minority shareholders attending the meeting; Oppose 400 shares, accounting for 0.0051% of the shares held by minority shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.8348% of the shares held by minority shareholders attending the meeting.
(II) review and approve the work report of the board of supervisors in 2021
Voting results: 77046128 shares were approved, accounting for 985084% of the shares held by all shareholders attending the meeting; Against 1101600 shares, accounting for 1.4085% of the shares held by all shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.0831% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6620040 shares, accounting for 850179% of the shares held by minority shareholders attending the meeting; Against 1101600 shares, accounting for 141473% of the shares held by minority shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.8348% of the shares held by minority shareholders attending the meeting.
(III) deliberating and adopting the full text of the 2021 annual report and its summary
Voting results: 78147328 shares were approved, accounting for 999164% of the shares held by all shareholders attending the meeting; Oppose 400 shares, accounting for 0.0005% of the shares held by all shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.0831% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the company’s shares: 7721240 shares, accounting for 991600% of the shares held by minority shareholders attending the meeting; Oppose 400 shares, accounting for 0.0051% of the shares held by minority shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.8348% of the shares held by minority shareholders attending the meeting.
(IV) deliberating and adopting the financial final accounts report of 2021
Voting results: 77046128 shares were approved, accounting for 985084% of the shares held by all shareholders attending the meeting; Against 1101600 shares, accounting for 1.4085% of the shares held by all shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.0831% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6620040 shares, accounting for 850179% of the shares held by minority shareholders attending the meeting; Against 1101600 shares, accounting for 141473% of the shares held by minority shareholders attending the meeting; 65004 shares were abstained (including 0 shares by default due to non voting), accounting for 0.8348% of the shares held by minority shareholders attending the meeting.
(V) review and approve the profit distribution plan for 2021
Voting results: 78147228 shares were approved, accounting for 999162% of the shares held by all shareholders attending the meeting; Against 65504 shares, accounting for 0.0838% of the shares held by all shareholders attending the meeting; Abstain 0 shares (including 0 shares by default due to non voting), accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 7721140 shares, accounting for 991588% of the shares held by minority shareholders attending the meeting; Against 65504 shares, accounting for 0.0000% of the shares held by minority shareholders attending the meeting.
(VI) the special audit statement on the occupation of funds by the company’s controlling shareholders and other related parties was reviewed and approved, and the related shareholders Guangdong Zhiguang Biotechnology Co., Ltd. and Beijing Century Tianfu venture capital center (limited partnership) avoided the voting of this proposal.
Voting results: 5125944 shares were approved, accounting for 657034% of the shares held by all shareholders attending the meeting; Against 2671700 shares, accounting for 342453% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0513% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 5110944 shares were agreed, accounting for 656373% of the shares held by minority shareholders attending the meeting; Against 2671700 shares, accounting for 343113% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
(VII) deliberated and passed the proposal on appointing the company’s financial audit institution in 2022
Voting results: 75476128 shares were approved, accounting for 965011% of the shares held by all shareholders attending the meeting; Against 2732604 shares, accounting for 3.4938% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0051% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 5050040 shares, accounting for 648551% of the shares held by minority shareholders attending the meeting; Against 2732604 shares, accounting for 350935% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
(VIII) deliberated and passed the proposal on the company’s application for comprehensive bank credit line in 2022
Voting results: 76638332 shares were approved, accounting for 979870% of the shares held by all shareholders attending the meeting; 1570400 shares opposed, accounting for 2.0079% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0051% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6212244 shares were agreed, accounting for 797808% of the shares held by minority shareholders attending the meeting; Against 1570400 shares, accounting for 201679% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
(IX) deliberated and passed the proposal on the company’s election of candidates for non independent directors
Voting results: 76638332 shares were approved, accounting for 979870% of the shares held by all shareholders attending the meeting; 1570400 shares opposed, accounting for 2.0079% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0051% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6212244 shares were agreed, accounting for 797808% of the shares held by minority shareholders attending the meeting; Against 1570400 shares, accounting for 201679% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
(x) deliberated and passed the proposal on Amending the articles of Association
Voting results: 77107132 shares were approved, accounting for 985864% of the shares held by all shareholders attending the meeting; Against 1101600 shares, accounting for 1.4085% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0051% of the shares held by all shareholders attending the meeting
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6681044 shares, accounting for 858013% of the shares held by minority shareholders attending the meeting; Against 1101600 shares, accounting for 141473% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
（11） The proposal on investment and construction of Tianhao Zhongshan pharmaceutical science and technology project was deliberated and adopted
Voting results: 77104332 shares were approved, accounting for 985828% of the shares held by all shareholders attending the meeting; Against 1104400 shares, accounting for 1.4120% of the shares held by all shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0051% of the shares held by all shareholders attending the meeting.
Voting results of shareholders other than shareholders who individually or jointly hold more than 5% of the shares of the company: 6678244 shares were agreed, accounting for 857654% of the shares held by minority shareholders attending the meeting; Oppose 1104400 shares, accounting for 141833% of the shares held by minority shareholders attending the meeting; Abstained 4000 shares (including 0 shares by default due to non voting), accounting for 0.0514% of the shares held by minority shareholders attending the meeting.
3、 Legal opinions issued by lawyers
Guangdong lianyue law firm appointed lawyers Chen Xiaoling and Wang Yingxin to attend the meeting and issued the following legal opinions: “the
